Common use of Black Scholes Value Clause in Contracts

Black Scholes Value. Notwithstanding the foregoing and the provisions of Section 4(b) above, in the event of a Fundamental Transaction (including, without limitation, a Fundamental Transaction that occurs prior to the Initial Exercise Date) (other than a Fundamental Transaction resulting solely from a merger or consolidation in which the Company is the surviving entity, the Common Stock continues to be publicly traded on an Eligible Market (other than the TSX) following such merger or consolidation and an amount of shares of Common Stock which is less than 20% of the Company’s issued and outstanding shares of Common Stock outstanding immediately prior to such merger or consolidation are issued in connection with such merger or consolidation), if the Holder has not exercised this Warrant in full prior to the consummation of such Fundamental Transaction, at the request of the Holder delivered before the ninetieth (90th) day after the consummation of such Fundamental Transaction, the Company or the Successor Entity (as the case may be) shall purchase this Warrant from the Holder on the date of such request by paying to the Holder cash in an amount equal to the Black Scholes Value of the unexercised portion of this Warrant that remained on the date of the consummation of such Fundamental Transaction.

Appears in 2 contracts

Samples: Warrant Agreement (Hydrogenics Corp), Securities Purchase Agreement (Hydrogenics Corp)

AutoNDA by SimpleDocs

Black Scholes Value. Notwithstanding the foregoing and the provisions of Section 4(b) above, in at the event request of a the Holder delivered at any time commencing on the earlier to occur of the public disclosure of any Fundamental Transaction (including, without limitation, a or the consummation of any Fundamental Transaction that occurs prior to the Initial Exercise Date) (other than a Fundamental Transaction resulting solely from a merger or consolidation in which the Company is the surviving entity, the Common Stock continues to be publicly traded on an Eligible Market (other than the TSX) following such merger or consolidation (as the case may be) and an amount the aggregate number of shares of Common Stock which issued (including, without limitation, shares of Common Stock issued or issuable upon conversion, exercise or exchange of all Convertible Securities and Options) in connection with such merger or consolidation (as the case may be) is less than 20% of the Company’s issued and outstanding shares of Common Stock outstanding immediately prior to such merger or consolidation are issued in connection with (as the case may be)) through the date that is ninety (90) days after the later to occur of (i) the public disclosure of such merger or consolidation)Fundamental Transaction, if the Holder has not exercised this Warrant in full prior to (ii) the consummation of such Fundamental Transaction, at the request of Transaction and (iii) the Holder delivered before the ninetieth (90th) day after the consummation becoming aware of such Fundamental TransactionTransaction if such Fundamental Transaction was not publicly disclosed, the Company or the Successor Entity (as the case may be) shall purchase this Warrant from the Holder on the date of such request by paying to the Holder cash in an amount equal to the Black Scholes Value of the unexercised portion of this Warrant that remained on the date of the consummation of such Fundamental TransactionValue.

Appears in 2 contracts

Samples: Provectus Pharmaceuticals Inc, Provectus Pharmaceuticals Inc

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.